New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
Publishing timestamp: 2023-07-29 09:49:54
Summary
The article discusses the upcoming arrival of new Covid vaccines in the US in the fall, targeting the omicron subvariant XBB.1.5. However, it highlights the potential challenges in getting Americans to take these vaccines, including pandemic fatigue, the belief that Covid is "over," and confusion over personal risk levels. The article suggests that public health officials and healthcare providers can potentially increase vaccine uptake by communicating that Covid vaccines will become a routine part of protecting one's health. It also discusses the confusion surrounding personal risks and benefits of getting another shot and the potential impact of the shift to a commercial market for vaccine distribution.
Sentiment: MIXED
Keywords: immunizations, moderna inc, biotechnology, pfizer inc, vaccinations, novavax inc, science, social issues, biotech and pharmaceuticals, covid-19 vaccine rollout, covid-19 pandemic, business news, pharmaceuticals, covid-19, business, health care industry, coronavirus, united states,
Source: https://www.cnbc.com/2023/07/29/covid-vaccine-what-uptake-of-new-shots-could-look-like.html